Korsana Biosciences (KRSA) Accounts Payables (2018 - 2025)
Korsana Biosciences' Accounts Payables came in at $508,000 for Q4 2025, up 30.3% from $390,000 a year earlier and up 5.8% from the prior quarter.
Powered by 
Analysis
Korsana Biosciences (KRSA) Accounts Payables (2018 - 2025) Analysis & Trends
Going back to Q4 2018, Korsana Biosciences' Accounts Payables data covers 29 quarters.
- Accounts Payables carries a five-year compound annual growth rate of -15.1% (FY2020 to FY2025).
- Going back by year, Accounts Payables was $390,000 in FY2024 (-67.4%), $1.2 million in FY2023 (-59.7%), $2.97 million in FY2022 (+62.5%) and $1.83 million in FY2021 (+59.1%).
- The Q4 2025 figure represents the highest quarterly Accounts Payables since Q2 2024.
- Year-over-year, Accounts Payables increased in two of the last eight quarters, with an average decline of 31.5%.
- The fastest year-over-year change in Accounts Payables over five years came in Q1 2022 (growth of 130.0%), and the weakest in Q1 2024 (a decline of 81.1%).
- Business Quant data shows KRSA's Accounts Payables at $480,000 (Q3 2025), $462,000 (Q2 2025) and $483,000 (Q1 2025) in the three quarters before Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 9.22 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 3.83 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.58 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Korsana Biosciences | 16.89 Mn | 2.44 Mn | - | 508,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 508,000.00 |
| Sep 30, 2025 | 480,000.00 |
| Jun 30, 2025 | 462,000.00 |
| Mar 31, 2025 | 483,000.00 |
| Dec 31, 2024 | 390,000.00 |
| Sep 30, 2024 | 304,000.00 |
| Jun 30, 2024 | 651,000.00 |
| Mar 31, 2024 | 741,000.00 |
| Dec 31, 2023 | 1.20 Mn |
| Sep 30, 2023 | 814,000.00 |
| Jun 30, 2023 | 1.86 Mn |
| Mar 31, 2023 | 3.93 Mn |
| Dec 31, 2022 | 2.97 Mn |
| Sep 30, 2022 | 1.65 Mn |
| Jun 30, 2022 | 2.77 Mn |
| Mar 31, 2022 | 2.52 Mn |
| Dec 31, 2021 | 1.83 Mn |
| Sep 30, 2021 | 1.17 Mn |
| Jun 30, 2021 | 1.39 Mn |
| Mar 31, 2021 | 1.10 Mn |
API Access
Korsana Biosciences Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=KRSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "KRSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=KRSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();